Xylazine: An Undercover Antagonist in the Opioid Crisis

Xylazine, more commonly known as “tranq,” is a strong sedative that has been approved for veterinary use. Because xylazine is intended exclusively for veterinary use, its adverse effects on humans are not taken into consideration from a regulatory standpoint, putting users at risk. Its unique danger arises from its undetectability, as it’s not classified as […]